Related Experiment Video
Updated: Aug 20, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Deletion analysis and clinical correlations in patients with Xp21 linked muscular dystrophy
Ayfer Ulgenalp1, Ozlem Giray, Elçin Bora
1Department of Pediatrics, Dokuz Eylül University Faculty of Medicine, Izmir, Turkey.
Abstract:
We carried out molecular deletion analysis on 142 patients with Duchenne/Becker muscular dystrophy which covered 25 exons of the dystrophin gene. We also evaluated the results by comparing with the clinical findings and examples in the literature. A deletion ratio of 63.7% was achieved. Exon 46 was the most frequently affected region. Interestingly we also observed four cases with muscle promoter (Mp) region deletions which have been rarely reported in the literature.

